- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Lisdexamfetamine dimesilate – July 2014
LISDEXAMFETAMINE DIMESILATE, capsules, 30 mg, 50 mg & 70 mg, Vyvanse®, Shire Australia Pty Ltd
Last updated
8 November 2023